[go: up one dir, main page]

Ahn et al., 2007 - Google Patents

Achieving in-depth proteomics profiling by mass spectrometry

Ahn et al., 2007

Document ID
13317919279676006039
Author
Ahn N
Shabb J
Old W
Resing K
Publication year
Publication venue
ACS Chemical Biology

External Links

Snippet

Proteomics addresses the important goal of determining the chemistry and composition of proteins in biological samples. Mass-spectrometry-based strategies have been highly successful in identifying and profiling proteins in complex mixtures; however, although depth …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers

Similar Documents

Publication Publication Date Title
Ahn et al. Achieving in-depth proteomics profiling by mass spectrometry
Anderson et al. Identification and characterization of human proteoforms by top-down LC-21 tesla FT-ICR mass spectrometry
Garcia What does the future hold for top down mass spectrometry?
Panchaud et al. Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean
Liu et al. Accurate mass measurements in proteomics
Hsu et al. Beyond quantitative proteomics: signal enhancement of the a1 ion as a mass tag for peptide sequencing using dimethyl labeling
Hao et al. Mass defect-based N, N-dimethyl leucine labels for quantitative proteomics and amine metabolomics of pancreatic cancer cells
Tipton et al. Nano-LC FTICR tandem mass spectrometry for top-down proteomics: routine baseline unit mass resolution of whole cell lysate proteins up to 72 kDa
Vitorino et al. De novo sequencing of proteins by mass spectrometry
Swatkoski et al. Evaluation of microwave-accelerated residue-specific acid cleavage for proteomic applications
Tu et al. Systematic assessment of survey scan and MS2-based abundance strategies for label-free quantitative proteomics using high-resolution MS data
Kang et al. Quantitative analysis of mTRAQ-labeled proteome using full MS scans
Boyne et al. Tandem mass spectrometry with ultrahigh mass accuracy clarifies peptide identification by database retrieval
Gouw et al. Optimizing identification and quantitation of 15N-labeled proteins in comparative proteomics
Van Riper et al. Mass spectrometry-based proteomics: basic principles and emerging technologies and directions
Hart-Smith et al. Enhanced methylarginine characterization by post-translational modification-specific targeted data acquisition and electron-transfer dissociation mass spectrometry
Kelstrup et al. Pinpointing phosphorylation sites: Quantitative filtering and a novel site-specific x-ion fragment
Gorshkov et al. SuperQuant: a data processing approach to increase quantitative proteome coverage
Wang et al. A tutorial review of labeling methods in mass spectrometry-based quantitative proteomics
McAlister et al. Analysis of tandem mass spectra by FTMS for improved large-scale proteomics with superior protein quantification
Sherwood et al. Correlation between y-type ions observed in ion trap and triple quadrupole mass spectrometers
Ahmadi et al. Identification of poly (ethylene glycol) and poly (ethylene glycol)-based detergents using peptide search engines
Kline et al. High quality catalog of proteotypic peptides from human heart
Wilburn et al. CIDer: a statistical framework for interpreting differences in CID and HCD fragmentation
Lu et al. Mesh fragmentation improves dissociation efficiency in top-down proteomics